Bioluminescent protease assay
View Patent ↗A sensitive bioluminescent assay to detect proteases including caspases, trypsin and tryptase is provided.
1. A luminescent assay method to detect one or more proteases comprising:
a) combining a luciferase and an amino-modified luciferin or a carboxy-terminal protected derivative;
b) contacting a sample containing one or more proteases with the combined luciferase and amino-modified luciferin or a carboxy-terminal protected derivative thereof of step (a) to form a mixture, wherein the modification comprises the covalent linkage of a substrate for the protease to the amino group of aminoluciferin or the derivative thereof by a peptide bond, wherein the protease cleaves the substrate at the peptide bond in the mixture, and
c) detecting luminescence in the mixture, thereby detecting the presence of one or more proteases in the sample, wherein the luminescent assay is more sensitive than a corresponding assay with a conjugate comprising a fluorophore covalently linked to the substrate or a functional equivalent thereof.
2. The method of claim 1 , further comprising correlating luminescence with the amount of protease activity.
3. The method of claim 2 , which detects trypsin.
4. The method of claim 2 , which detects tryptase.
5. The method of claim 1 , wherein the protease is selected from trypsin or tryptase.
6. The method of claim 1 , which is at least 2 times more sensitive than a corresponding assay with a conjugate comprising rhodamine-110 covalently linked to the substrate.
7. The method of claim 1 , wherein the sample comprises a cell lysate.
8. The method of claim 7 , further comprising treating cells with an apoptosis-inducing agent prior to forming the cell lysate.
9. The method of claim 1 , wherein the luciferase is a thermostable luciferase.
10. The method of claim 1 , wherein the substrate is the carboxy-terminated derivative of aminoluciferin having formula (I):
wherein R is a peptide that is linked to the remainder of the compound of formula (I) through an arginine or lysine group at the C-terminus of the peptide forming a peptide bond; and R′ is H or a suitable carboxy-protecting group, or a suitable salt thereof.
11. The method claim 1 , wherein the luminescent assay is in a homogenous assay format.
12. A luminescent assay method to detect a protease that specifically cleaves a peptide substrate comprising lysine or arginine comprising:
a) combining a luciferase and an amino-modified luciferin or a carboxy-terminal protected derivative;
b) contacting the combined luciferase and the amino-modified luciferin or carboxy-terminal protected derivative thereof of step a) with a sample containing one or more proteases that specifically cleaves a peptide substrate comprising lysine or arginine to form a mixture, wherein the modification comprises the covalent linkage of a substrate for the protease to the amino group of aminoluciferin or the derivative thereof by a peptide bond, wherein the protease cleaves the substrate at the peptide bond in the mixture, and
c) detecting luminescence in the mixture, thereby detecting the presence of the protease in the sample, wherein the luminescent assay is more sensitive than a corresponding assay with a conjugate comprising a fluorophore covalently linked to the substrate or a functional equivalent thereof.
13. The method of claim 12 , further comprising correlating luminescence with the amount of protease activity.
14. The method of claim 12 , which detects trypsin or tryptase.
15. The method of claim 12 , wherein the luminescent assay is in a homogenous assay format.
16. The method of claim 12 , which is at least 2 times more sensitive than a corresponding assay with a conjugate comprising rhodamine-110 covalently linked to the substrate.
17. The method of claim 12 wherein the sample comprises a cell lysate.
18. The method of claim 17 , wherein the cells are treated with an apoptosis-inducing agent prior to lysis.
19. The method of claim 12 , wherein the luciferase is a thermostable luciferase.
20. The method of claim 12 , wherein the substrate is the carboxy-terminated derivative of aminoluciferin having formula (I):
wherein R is a peptide that is linked to the remainder of the compound of formula (I) through an arginine or lysine group at the C-terminus of the peptide forming a peptide bond; and R′ is H or a suitable carboxy-protecting group, or a suitable salt thereof.